January 21

　　With the approval of the Beijing Municipal Intellectual Property Office, our company has been selected as one of the 100 pilot enterprises for the 2005 Zhongguancun Science and Technology Park “Patent Engine” Program.

　　March 9

　　Mr. Hitoshi Kamiya from Itochu Corporation of Japan visited our company. Through mutual exchanges and in-depth discussions, both sides expressed great confidence and high expectations for further cooperation in the future.

　　April 8

　　NORTHLAND and the Affiliated Hospital of Chengde Medical College jointly held an academic conference on "Gene Therapy and Ischemic Diseases." NORTHLAND and the Affiliated Hospital of Chengde Medical College signed a cooperation agreement regarding the pharmacodynamic evaluation of NL003.

　　April 9

　　Mr. Kim Sun-young, a professor at the Institute of Genetic Engineering at Seoul National University in South Korea and president of ViroMed, along with a delegation of four others, paid a two-day visit to NORTHLAND for exchanges and reached a consensus on mutually promoting new drug development.

　　September 15

　　The 15th National Invention Exhibition was held at the China Agricultural Exhibition Hall. NORTHLAND’s NL003 new drug project participated in the exhibition and received great attention and positive feedback from visitors.

　　November 9

　　The NORTHLAND NL003 project received a non-repayable grant of 750,000 yuan from the National Science and Technology Innovation Fund for Small and Medium-sized Enterprises in 2005 (project approval code: 05C26221100005).